Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report

We report a patient with prostate cancer found 2 years after percutaneous arterial embolization (PAE) of the prostate with a rapid increase in prostate specific antigen (PSA) 3 months later, even though the initial result was low. He did not consult a urologist during or after PAE until acute urinar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ying-Chieh, Chen, Szu-Ju, Huang, Wei-Hsuan, Huang, Chi-Ping, Chen, Yung-Hsiang, Chen, Wen-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Interesting Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600189/
https://www.ncbi.nlm.nih.gov/pubmed/36292067
http://dx.doi.org/10.3390/diagnostics12102378
_version_ 1784816779746344960
author Chang, Ying-Chieh
Chen, Szu-Ju
Huang, Wei-Hsuan
Huang, Chi-Ping
Chen, Yung-Hsiang
Chen, Wen-Chi
author_facet Chang, Ying-Chieh
Chen, Szu-Ju
Huang, Wei-Hsuan
Huang, Chi-Ping
Chen, Yung-Hsiang
Chen, Wen-Chi
author_sort Chang, Ying-Chieh
collection PubMed
description We report a patient with prostate cancer found 2 years after percutaneous arterial embolization (PAE) of the prostate with a rapid increase in prostate specific antigen (PSA) 3 months later, even though the initial result was low. He did not consult a urologist during or after PAE until acute urinary retention developed. The clinical stage was cT2cN1M1b with Gleason grade 5 + 5 = 10. An increase in PSA a short interval after PAE may suggest the presence of prostate cancer. We suggest that patients undergoing PAE should consult a urologist, and that PSA levels should be checked every 3 months in the first year after PSA.
format Online
Article
Text
id pubmed-9600189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96001892022-10-27 Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report Chang, Ying-Chieh Chen, Szu-Ju Huang, Wei-Hsuan Huang, Chi-Ping Chen, Yung-Hsiang Chen, Wen-Chi Diagnostics (Basel) Interesting Images We report a patient with prostate cancer found 2 years after percutaneous arterial embolization (PAE) of the prostate with a rapid increase in prostate specific antigen (PSA) 3 months later, even though the initial result was low. He did not consult a urologist during or after PAE until acute urinary retention developed. The clinical stage was cT2cN1M1b with Gleason grade 5 + 5 = 10. An increase in PSA a short interval after PAE may suggest the presence of prostate cancer. We suggest that patients undergoing PAE should consult a urologist, and that PSA levels should be checked every 3 months in the first year after PSA. MDPI 2022-09-30 /pmc/articles/PMC9600189/ /pubmed/36292067 http://dx.doi.org/10.3390/diagnostics12102378 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Interesting Images
Chang, Ying-Chieh
Chen, Szu-Ju
Huang, Wei-Hsuan
Huang, Chi-Ping
Chen, Yung-Hsiang
Chen, Wen-Chi
Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
title Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
title_full Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
title_fullStr Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
title_full_unstemmed Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
title_short Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
title_sort prostate cancer after percutaneous arterial embolization of the prostate: a case report
topic Interesting Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600189/
https://www.ncbi.nlm.nih.gov/pubmed/36292067
http://dx.doi.org/10.3390/diagnostics12102378
work_keys_str_mv AT changyingchieh prostatecancerafterpercutaneousarterialembolizationoftheprostateacasereport
AT chenszuju prostatecancerafterpercutaneousarterialembolizationoftheprostateacasereport
AT huangweihsuan prostatecancerafterpercutaneousarterialembolizationoftheprostateacasereport
AT huangchiping prostatecancerafterpercutaneousarterialembolizationoftheprostateacasereport
AT chenyunghsiang prostatecancerafterpercutaneousarterialembolizationoftheprostateacasereport
AT chenwenchi prostatecancerafterpercutaneousarterialembolizationoftheprostateacasereport

Ejemplares similares